When fat cells invade the liver, they can cause inflammation that leaves disruptive scars—known as fibrosis—linked to cirrhosis and other liver diseases. Obesity is the most prevalent metabolic risk for liver fibrosis. The second major risk for liver scarring is alco…
Every year we survey individuals who use our resources and services, and to whom we provide funding. Attached you'll find a report summarizing the outcomes reported from calendar year 2021. This year’s report is unique in that we have applied the four areas of impact…
A recipient of the SC CTSI Mentored Career Development in Clinical and Translational Science award
More than half of diabetic patients who get a below-the-knee amputation die within five years.
A recipient of multiple SC CTSI funding awards, we hear from him about his experiences thus far participating in the KL2 Program, as well as his future plans.
Over nearly two decades, more and more patients have chosen stereotactic body radiation therapy (SBRT) as an alternative to surgery for certain kinds of early-stage lung cancer. SBRT deploys innovative techniques to target and deliver high levels of focused radiation doses to …
The SC CTSI Regulatory Knowledge and Support (RKS) group has made their mark on remote learning post-COVID with the launch of a new, interactive educational module chapter to add to their ongoing Clinical Trial Quality Training Series. “Remote Monitoring of a Clinical Trial Si…
SC CTSI collaborated with the National Center for Advancing Translational Sciences and other CTSAProgram hubs to implement The National Institutes of Health’s ACTIV-1 Immune Modulators Clinical Trial.
NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.